SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-004634
Filing Date
2017-08-03
Accepted
2017-08-02 19:31:23
Documents
6
Period of Report
2017-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080217.htm 8-K 38319
2 EXHIBIT 3.1 exh_31.htm EX-3.1 132296
3 EXHIBIT 3.2 exh_32.htm EX-3.2 93617
4 EXHIBIT 4.1 exh_41.htm EX-4.1 160952
5 EXHBIT 10.1 exh_101.htm EX-10.1 141277
6 EXHIBIT 99.1 exh_991.htm EX-99.1 8340
  Complete submission text file 0001171843-17-004634.txt   576388
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 171001753
SIC: 2836 Biological Products, (No Diagnostic Substances)